Beijing Kewei Clinical Diagnostic Reagent INC

COVID-19

Home   >   Products   >   Disease Category   >   Infectious Disease   >   COVID-19   >  

Multiple RapidRea-Time PCR kit for Detection of SARS-CoV-2

CLINICAL TRIAL in China, good Coincidence rate with over 500 clinical samples, CE mark approved UNIQUE TECHNOLOGY, inactivate virus and preserve RNA at room temperature

 

● CLINICAL TRIAL in China, good Coincidence rate with over 500 clinical samples, CE mark approved
● UNIQUE TECHNOLOGY, inactivate virus and preserve RNA at room temperature
● EASY TO USE, mix sample and lysis buffer, then do PCR amplification in machine
● TIME SAVING, from sample to result in 30 minutes QUALITY TRUST, Internal control inside to monitor the False Negative

Product advantage
■ Inactivating Virus during sample collection - safety and efficiency
The virus can be inactivated directly after the sample is placed into the preservation solution at room temperature without RNA degradation.
 
■ NOT NEED the RNA extraction and purification - easy to use, labor and time saving
DO NOT NEED the RNA extraction and purification any more, what customer needs to do is to add the sample already in preservation tube into the PCR tube, mixed with the lysis buffer and PCR buffer directly.
VERY EASY TO USE, The test can be started after mixing the enzyme with the reaction solution, no pipette is needed, suitable for POCT scenes.
 
■Triple PL .EX PCR amplification technique and Internal Control inside - monitoring the false negative
Detection the ORFIab gene ( FAM), E gene ( CY5 ) and internal control ( HEX/VIC ) in one tube at the same time, the recommended platform is YS-qPCR-1 ,ABI7500 and SLAN.

  • No Download Information
Support
Download Center
Distributor
Products